What is the NOAEL for Dimethyl sulfoxide?
Dimethyl sulfoxide has 67 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP ICE skin sensitization.
Also known as: Methyl sulfoxide, DMSO, Methane, sulfinylbis-, Caswell No. 381, Demasorb (+15 more)
CAS 67-68-5
Dimethyl sulfoxide (CAS 67-68-5) is a chemical substance. Key regulatory status: REACH registered, 14 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, ECHA REACH, ILO ICSC.
View cosmetic safety profile for DMSO (Dimethyl Sulfoxide) →
Dimethyl sulfoxide is prohibited in EU cosmetics but has active industrial GHS classifications (H315, H319, H335, H227, H371).
CAS, identifiers, formula, and alternate names for the matched substance record.
International Chemical Safety Card hazard and exposure summary.
| Field | Value |
|---|---|
| GHS Signal Word | WARNING |
| GHS Hazard Statements | Combustible liquid |
| Short-term Effects | The substance is mildly irritating to the eyes and skin. Exposure to high concentrations could cause lowering of consciousness. May accelerate skin absorption of other materials. See Notes. |
| Long-term Effects | The substance defats the skin, which may cause dryness or cracking. |
| Routes of Exposure | The substance can be absorbed into the body by inhalation, through the skin and by ingestion. |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| active_ingredient; Australia | Australian Pesticides and Veterinary Medicines Authority | CPCat |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| pharmaceutical | US International Trade Commission | CPCat |
| pharmaceutical | FDA | United States Food and Drug Administration (FDA) |
| pharmaceutical | FDA | United States Food and Drug Administration (FDA) |
| pharmaceutical | FDA | United States Food and Drug Administration (FDA) |
| food_additive; Substances Added to Food (formerly EAFUS) (2/2019) | FDA | United States Food and Drug Administration (FDA) |
| Canada; pharmaceutical | DrugBank | DrugBank |
| banned; Europe; Personal care | European Commission | CosIng |
| active_ingredient; animal_products; Europe; pharmaceutical; residue | EU | CPCat |
| pharmaceutical | FDA | United States Food and Drug Administration (FDA) |
| pharmaceutical | FDA | United States Food and Drug Administration (FDA) |
| IFRA Transparency | IFRA | IFRA |
| Europe | European Commission | Fl@vis |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 4895 | ug/mL | CD54, EC200 | Dermal | - | NTP ICE skin sensitization |
| >200 | ug/mL | CD86, EC150 | Dermal | - | NTP ICE skin sensitization |
| 5000 | ug/mL | CV75 | Dermal | - | NTP ICE skin sensitization |
| =17.67 | mg/m3 | DNEL local | inhalation | Human | ToxValDB GESTIS DNEL |
| =75 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB GESTIS DNEL |
| 7.3 | unitless | Draize rabbit irritation score | Ocular | Rabbit | NTP ICE eye irritation |
| >2000 | uM | EC1.5 | Dermal | - | NTP ICE skin sensitization |
| 72 | % | EC3 | Dermal | Mouse | NTP ICE skin sensitization |
| 3 | unitless | EPA Classification | Ocular | Rabbit | NTP ICE eye irritation |
| YOW8V9698H | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 1.23 | ratio | Imax | Dermal | - | NTP ICE skin sensitization |
| 0 | % | Incidence of positive responses | Dermal | Human | NTP ICE skin sensitization |
| 4.655e+4 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP ICE skin sensitization |
| 0.11 | %/sec | Intensity | Ocular | - | NTP ICE eye irritation |
| =1.450e+4 | mg/kg bw | LD50 | oral | Rat | NTP ICE acute oral |
| =2.830e+4 | mg/kg bw | LD50 | oral | Rat | NTP ICE acute oral |
| =1800 | mg/kg bw/day | LEL | injection | Mouse | ECHA |
| =8.308e+4 | mg/m3 | LEL | inhalation | Human | ToxValDB DOE Protective Action Criteria |
| =2.783 | mg/L | LOAEC | inhalation | Rat | ToxValDB HPVIS |
| =5380 | mg/m3 | LOAEC | inhalation | Rat | ECHA |
| =660 | mg/kg bw/day | LOAEL | dermal | Dog | ECHA |
| =750 | mg/kg bw/day | LOAEL | injection | Rat | ECHA |
| =990 | mg/kg bw/day | LOAEL | dermal | Monkey | ECHA |
| =1650 | mg/kg bw/day | LOAEL | dermal | Rabbit | ECHA |
| =2000 | mg/kg bw/day | LOAEL | oral | Mouse | ToxValDB HPVIS |
| =2500 | mg/kg bw/day | LOAEL | oral | Dog | ToxValDB HPVIS |
| =2970 | mg/kg bw/day | LOAEL | dermal | Pig | ECHA |
| =4950 | mg/kg bw/day | LOAEL | dermal | Rabbit | ECHA |
| =5000 | mg/kg bw/day | LOAEL | dermal | Rabbit | ECHA |
| =8910 | mg/kg bw/day | LOAEL | oral | Monkey | ECHA |
| =9900 | mg/kg bw/day | LOAEL | oral | Rat | ECHA |
| =1.100e+4 | mg/kg bw/day | LOAEL | dermal | Monkey | ECHA |
| =25 | uL | LOEL | dermal | Mouse | ToxValDB ECOTOX |
| >180 | s | Lag time | Ocular | - | NTP ICE eye irritation |
| 0 | unitless | Model Score | - | - | NTP ICE endocrine |
| =0.2 | mg/L | NOAEC | inhalation | Rat | ToxValDB HPVIS |
| =0.964 | mg/L | NOAEC | inhalation | Rat | ToxValDB HPVIS |
| =964 | mg/m3 | NOAEC | inhalation | Rat | ECHA |
| =1390 | mg/m3 | NOAEC | inhalation | Rat | ECHA |
| =2783 | mg/m3 | NOAEC | inhalation | Rat | ECHA |
| =2793 | mg/m3 | NOAEC | inhalation | Rat | ECHA |
| >2800 | mg/m3 | NOAEC | inhalation | Rat | ECHA |
| <300 | mg/kg bw/day | NOAEL | injection | Dog | ECHA |
| =500 | mg/kg bw/day | NOAEL | injection | Rat | ECHA |
| =825 | mg/kg bw/day | NOAEL | dermal | Pig | ECHA |
| =1000 | mg/kg bw/day | NOAEL | oral | Rabbit | ECHA |
| =1000 | mg/kg bw/day | NOAEL | oral | Rat | EFSA |
| =1000 | mg/kg bw/day | NOAEL | oral: gavage | Rat | EFSA |
| =1100 | mg/kg bw/day | NOAEL | dermal | Dog | ECHA |
| =1100 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB HPVIS |
Showing 50 of 67 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Dimethyl sulfoxide | 200-664-3 | ECHA overview → |
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Same-CAS food additive, ADI, and GRAS records where available.
1 food-safety record found.
View full food safety profile →Same-CAS cannabis compliance and lab records where available.
1 cannabis record found in efsa substances.
View full cannabis profile →Dimethyl sulfoxide has 67 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP ICE skin sensitization.
Dimethyl sulfoxide appears on 9 regulatory/inventory lists including active_ingredient; Australia, inert_ingredient; non_food_use; Pesticides, pharmaceutical, and 6 more. Source: EPA CPDat.
Yes, Dimethyl sulfoxide is also indexed as a cosmetic ingredient under the name DMSO (Dimethyl Sulfoxide). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, ECHA REACH, ILO/WHO ICSC, CosIng / Ingredients DB, ChEMBL / DailyMed, EFSA / FDA GRAS, cannabis regulatory/lab databases. All data traces to primary regulatory sources and is updated from official government databases.
Dimethyl sulfoxide is prohibited in EU cosmetics but has active industrial GHS classifications (H315, H319, H335, H227, H371).
Dimethyl sulfoxide also appears in cosmetics, pharmaceutical, food safety, cannabis databases.